These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26096232)

  • 1. The association between endometriosis and survival outcomes of ovarian cancer: Evidence-based on a meta-analysis.
    Yang B; Wang D; Chen H; Yang F
    Niger J Clin Pract; 2015; 18(5):577-83. PubMed ID: 26096232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.
    Kim HS; Kim TH; Chung HH; Song YS
    Br J Cancer; 2014 Apr; 110(7):1878-90. PubMed ID: 24518590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity?
    Bounous VE; Ferrero A; Fuso L; Ravarino N; Ceccaroni M; Menato G; Biglia N
    Anticancer Res; 2016 Jul; 36(7):3445-9. PubMed ID: 27354606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
    Erzen M; Rakar S; Klancnik B; Syrjänen K
    Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
    Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
    Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
    [No Abstract]   [Full Text] [Related]  

  • 6. Association Between Endometriosis and Prognosis of Ovarian Cancer: An Updated Meta-Analysis.
    Chen P; Zhang CY
    Front Oncol; 2022; 12():732322. PubMed ID: 35433452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
    Bassiouny D; El-Baz MA; Gamil TM; Shams N; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Chiu HF; Naeim M; Li N; Nofech-Mozes S; Khalifa MA
    Int J Gynecol Pathol; 2019 Sep; 38(5):435-442. PubMed ID: 30059454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis.
    Kim HS; Kim MA; Lee M; Suh DH; Kim K; No JH; Chung HH; Kim YB; Song YS
    Ann Surg Oncol; 2015 Aug; 22(8):2738-45. PubMed ID: 25680339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
    Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
    J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Presence of Endometriosis Affect Prognosis of Ovarian Cancer?
    Dinkelspiel HE; Matrai C; Pauk S; Pierre-Louis A; Chiu YL; Gupta D; Caputo T; Ellenson LH; Holcomb K
    Cancer Invest; 2016; 34(3):148-54. PubMed ID: 26986692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.
    Bai H; Cao D; Yuan F; Sha G; Yang J; Chen J; Wang Y; Zhang Z; Shen K
    Gynecol Oncol; 2016 Dec; 143(3):526-531. PubMed ID: 27745918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis.
    Lu J; Tao X; Zhou J; Lu Y; Wang Z; Liu H; Xu C
    Oncotarget; 2017 Jan; 8(4):5843-5852. PubMed ID: 27992377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
    Cuff J; Longacre TA
    Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.
    Xu K; Yang S; Zhao Y
    Oncotarget; 2017 Jan; 8(1):285-302. PubMed ID: 27690218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Clinical Characteristics and Prognostic Factors Related to EMs Correlation in Ovarian Cancer Patients.
    Zheng Q; Chen S; Chen L; Wang J
    Altern Ther Health Med; 2024 Aug; 30(8):104-107. PubMed ID: 38290463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of ovarian carcinoma for women with ovarian endometrioma aged 45 years and older in China.
    He ZX; Shi HH; Fan QB; Zhu L; Leng JH; Sun DW; Li ZF; Shen K; Wang S; Lang JH
    J Ovarian Res; 2017 Jul; 10(1):45. PubMed ID: 28716151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials.
    Wu YS; Shui L; Shen D; Chen X
    Oncotarget; 2017 Feb; 8(6):10703-10713. PubMed ID: 27793044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
    Tian C; Song W; Tian X; Sun Y
    Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis.
    Yu L; Deng L; Li J; Zhang Y; Hu L
    Gynecol Oncol; 2013 Feb; 128(2):391-6. PubMed ID: 23142075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.